The Hunt for the Next 10 Bagger

[wdk1227]

News out on CBAI- signing deals!

LAS VEGAS, Jan 04, 2010 /PRNewswire-FirstCall via COMTEX/ -- Cord Blood
America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell
preservation company (http://www.cordblood-america.com) focused on bringing the
life saving potential of stem cells, a biological insurance policy, to families
nationwide and internationally, said today that it has signed a Letter of Intent
to process and store cord blood specimens for BioCells, Inc., headquartered in
Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto
Rico.

"This is an excellent example of how our new laboratory and storage facility in
Las Vegas allows us to significantly diversify our business model," said Matthew
Schissler, co-founder and CEO. "BioCells is already the second largest stem cell
storage company in Argentina with annual revenues of 1.5M (USD). The company has
12 locations throughout the country and has recently expanded internationally to
both Uruguay and Paraguay. We are confident this will be an excellent working
relationship, beneficial to both companies. We will be processing and storing
for BioCells' affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico."

"It is a revenue generator we have not had in the past. Not only do we have our
own organic sales engine, our new lab can now generate gross profit by
processing and storage agreements with other successful stem cell companies,"
Mr. Schissler commented. "BioCells has proven to be a tremendous company and we
are fortunate to have entered into this letter of intent."

Cord Blood America recently announced a grand opening of its 17,000 square foot
stem cell laboratory and headquarters in Las Vegas, near the city's
international airport, on January 22, 2010.

The deal between Cord Blood America and BioCells is pending due diligence, and
if it is completed successfully, anticipates the contract closing in the first
quarter of 2010.

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell,
which facilitates umbilical cord blood stem cell preservation for expectant
parents and their children. Its mission is to be the most respected stem cell
preservation company in the industry. Collected through a safe and non-invasive
process, cord blood stem cells offer a powerful and potentially life-saving
resource for treating a growing number of ailments, including cancer, leukemia,
blood, and immune disorders. To find out more about Cord Blood America, Inc.
(OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor
information, visit www.cordblood-america.com.